ResMed Inc (RMD)
NYSE · Healthcare · Medical Instruments & Supplies
ResMed Inc is a Healthcare company with a market capitalization of $29.05B, a trailing P/E ratio of 19.3, and a dividend yield of 1.17%.
5-Year Price History
Latest Annual Financials · FY ending June 30, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q3 2026 | April 30, 2026 | $2.86 | $2.80 | +2.1% |
| Q2 2025 | January 29, 2026 | $2.81 | $2.72 | +3.3% |
| Q1 2025 | October 30, 2025 | $2.37 | $2.44 | -2.9% |
| Q4 2025 | July 31, 2025 | $2.55 | $2.48 | +2.8% |
| Q3 2025 | April 23, 2025 | $2.37 | $2.36 | +0.4% |
| Q2 2024 | January 30, 2025 | $2.43 | $2.31 | +5.2% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is ResMed Inc's market cap?
As of June 29, 2026, ResMed Inc (RMD) has a market capitalization of $29.05B.
What is ResMed Inc's P/E ratio?
ResMed Inc trades at a trailing price-to-earnings (P/E) ratio of 19.3. Its forward P/E is 16.9.
Does ResMed Inc pay a dividend?
Yes — ResMed Inc pays a dividend yielding 1.17%, an annual payout of $2.33 per share.
What sector is RMD in?
ResMed Inc is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was ResMed Inc's revenue?
In its latest reported fiscal year (ending June 30, 2025), ResMed Inc reported revenue of $5.15B and net income of $1.40B.
Ask your own questions about RMD
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.